Screener / SEC EDGAR /CIK 0001838359 /10-K filed Mar 4, 2026, compared with Mar 7, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · IT Services

Rigetti Computing, Inc. RGTI

Compare with peers Embed
The 10-K against last year's

264 changes: 27 added, 104 removed, 129 reworded, 4 quiet changes

10-K Mar 4, 2026 vs Mar 7, 2025

10-K 0001104659-26-023454 (Mar 4, 2026) vs 10-K 0001558370-25-002499 (Mar 7, 2025) Not compared: Legal Proceedings, Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

277 paragraphs · 11 new · 109 reworded · 91 gone · 10-K Mar 4, 2026 against Mar 7, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 267 · 48% changed Every version of it
Beginning on We also have the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect ability to exercise their warrants on a cashless basis and could potentially receive up to a maximum of 0.361 shares of Common Stock per warrant or a minimum of 0.034 shares of Common Stock per warrant. The number of shares of Common Stock that a warrant holder will ultimately receive upon a cashless exercise in connection with redeem all outstanding Public Warrants, at a redemption by us, is based on price of $0.10 per warrant, provided that the fair market value of our Common Stock on the redemption date, determined based on the volume weighted average last reported sales price of our Common Stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the 10 trading days ending like) on the third trading day prior to the date on which we provide notice of redemption. In this circumstance, holders may elect to exercise their warrants for cash on a cashless basis during the notice period. The number of redemption is sent shares of Common Stock issuable upon such cashless exercise ranges from 0.034 to 0.361 shares per warrant, depending on the holders fair market value of the Common Stock and the remaining term of the warrants, as determined pursuant to the warrant agreement. The value received upon exercise may be less than the value that could have been realized had the warrants been exercised at a later time, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, as shares issuable is subject to a contractual cap set forth in a table in the warrant agreement.
Paragraph 202 · 48% changed Every version of it
Although we monitor our use of open-source software to avoid subjecting our platform to conditions we do not intend to attach to such platform or our proprietary code, we cannot assure you that our processes for controlling such use will be effective. If we are held to have breached the terms of an open-source software license, we could be required to seek licenses from third parties to continue operating using our solution on terms that are not economically feasible, to re-engineer our solution or the supporting computational infrastructure to discontinue use of code, or to make generally available, in source code form, portions of our proprietary code. This could allow our competitors to create similar solutions with lower development effort and time and ultimately put us at a competitive disadvantage.
Paragraph 191 · 43% changed Every version of it
If a third party is able to obtain an injunction preventing us from using or accessing such third-party intellectual property rights, or if we cannot license or develop alternative technology for any infringing aspect of our business, we may be forced to limit or stop sales of our products, services or technologies or cease business activities related to such intellectual property. Although we carry general liability insurance, our insurance may not cover potential claims of this type or may not be adequate to indemnify us for all liability that may be imposed. We cannot predict the outcome of lawsuits and cannot ensure that the results of any such actions will not have an adverse effect on our business, financial condition or results of operations. Even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm our business and operating results. Further, there could be public announcements of the intellectual property litigation, and if securities analysts, investors or others perceive the potential impact to be negative or risks to be substantial, it could have an adverse effect on the price of our Common Stock.
Paragraph 268 · 43% changed Every version of it
If the Company were to redeem the Public Warrants, this may require holders to: (i) exercise their Public Warrants and pay the exercise price therefore at a time when it may be economically disadvantageous to do so; (ii) sell their Public Warrants at the then-current market price; or (iii) accept the nominal redemption price, which is likely to be substantially less than the market value of the warrants at the time of redemption. None of the Private Warrants will be redeemable by us, subject to certain circumstances, so long as they are held by the Supernova Partners II LLC (“Supernova Sponsor”) or its permitted transferees.
Paragraph 59 · 41% changed Every version of it
Our potential customers tend Sales to be government agencies and large enterprises. Therefore, our future success will depend on our ability to effectively sell our products to such customers. Sales to these end-customers involve risks that may not be present (or that are present to a lesser extent) with sales to non-governmental agencies or smaller customers. agencies. The bidding process for government contracts can be highly competitive, expensive, and time-consuming, often requiring significant upfront time and expense without any assurance that these efforts will generate revenue. These risks include, but are not limited to, (i) entities may also have increased purchasing power and leverage held by such customers in negotiating contractual arrangements with us and (ii) us, as well as longer sales cycles and cycles, which brings the associated risk that substantial time and resources may be spent on a potential end-customer customer that elects not to purchase our solutions. products or services. Sales to government agencies are often fixed fee development contracts, which involve additional risks. See “-If our cost and time estimates for fixed fee arrangements do not accurately anticipate the cost of servicing those arrangements, we could experience losses on these arrangements or our profitability could be reduced. ”
Paragraph 100 · 40% changed Every version of it
Our future success is highly dependent on our ability to attract and retain our executive officers, key employees and other qualified personnel. As we build our brand and become more well known, there is an increased risk that competitors or other companies may seek to hire our personnel. The loss of the services provided by these individuals will have an adverse impact on the achievement of our business strategy. These individuals could leave our employment at any time, as they are “at will” employees. A loss of a member of senior management, or an engineer or other key employee particularly to a competitor, could also place us at a competitive disadvantage. Effective succession planning is also important to our long-term success and may cause disruption to our business due to, among other things, diverting management’s attention away from the operations of the business or causing a deterioration in morale. Failure to ensure effective transfer of knowledge and smooth transitions involving key employees could hinder our strategic planning and execution.
Paragraph 142 · 40% changed Every version of it
As applicable, such rights may include the right to access, correct, or delete certain personal data, and to opt-out of certain data processing activities, such as targeted advertising, profiling, and automated decision-making. The exercise of these rights may impact our business and ability to provide our products and services. Certain states jurisdictions also impose stricter requirements for processing certain personal data, including sensitive information, such as conducting data privacy impact assessments. These state laws allow for statutory fines for noncompliance. For example, the California Consumer Privacy Act amended by the California Privacy Rights Act of 2020 (“CCPA”), applies to personal data of consumers, business representatives, and employees who are California residents, and requires businesses to provide specific disclosures in privacy notices and honor requests of such individuals to exercise certain privacy rights. The CCPA provides for fines of up to $7,500 per intentional violation and allows private litigants affected by certain data breaches to recover significant statutory damages. Similar laws are being considered in several other states, as well as at the federal and local levels. These developments further complicate compliance efforts, and increase legal risk and compliance costs for us, and the third parties upon whom we rely.
Paragraph 223 · 39% changed Every version of it
The market price of our Common Stock could decline if holders of our shares sell them, including pursuant to resale registration statements, or are perceived by the market as intending to sell them. As such, sales Sales of a substantial number of shares of our Common Stock in the public market could occur at any time. These sales, market, including sales of our Common Stock by us or our affiliates, or the perception in the market that the holders of a large number of shares intend to sell shares, these sales may occur, could reduce the market price of our Common Stock.

MD&A

99 paragraphs · 16 new · 58 reworded · 13 gone · 10-K Mar 4, 2026 against Mar 7, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 90 · 50% changed
Revenue related to collaborative research services and professional services is recognized over time, based on hours or costs incurred. For fixed price milestone-based contracts, if a milestone is deemed probable of being met, revenue is recognized based on the input measure explained above as control is expected to transfer over the time period a milestone the performance obligation is completed. satisfied using an input measure based on actual labor hours or costs incurred. For those milestones not deemed probable of being met, revenue is recognized upon satisfaction of the performance obligation. Revenue related to the sale of QPUs and custom quantum computing components cost-share contracts is recognized at a point in time, and upon customer acceptance for custom quantum computing components. using an input based on actual reimbursable costs incurred.
Paragraph 53 · 49% changed
We believe that our existing balances of cash, cash equivalents and available-for-sale investments should be sufficient to meet our anticipated operating cash needs for at least the next three years based on our current business plan, and expectations and assumptions considering current macroeconomic conditions. Our operating plan may change because of factors currently unknown, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations or other transactions. In addition, we may seek additional capital even if we believe that we have sufficient funds for current or future operating plans. We have based these estimates on assumptions that may prove to be wrong and we could use our available capital resources sooner than we currently expect, and future capital requirements and the adequacy of available funds will depend on many factors including those described in the section titled “Risk Factors” in this Annual Report on Form 10-K. If we are unable to raise capital when needed and on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs and/or other efforts. A recession or market corrections resulting from the impact of macroeconomic conditions could materially affect our business and the value of our securities.
Paragraph 36 · 49% changed
We anticipate that R&D research and development expenditures will grow in the future as we continue to focus on our technology roadmap and long-term goal goals of achieving broad quantum advantage. advantage and large-scale fault tolerant quantum computing. In the future, we may seek to significantly increase our capital expenditures, including to upgrade our current chip fabrication facility, and possibly invest in a new quantum chip fabrication facility, which would require a significant amount of cash for capital expenditures and increase our depreciation expense in future years.
Paragraph 70 · 48% changed
A discussion of the change in the fair value of warrant liabilities is included in See Note 9 19 to our consolidated financial statements for the year ended December 31, 2024, included elsewhere located in “Part II Item 8 – Financial Statements and Supplementary Data. Notes to Consolidated Financial Statements” in this Annual Report on Form 10-K. 10-K for a description of our contractual obligations and contingencies.
Paragraph 18 · 48% changed
In February 2025, our wholly-owned subsidiary, Rigetti Sub, entered into the Collaboration Agreement with Quanta, whereby the parties may enter into written statements of work from time to time pursuant to which Quanta will develop Covered Components listed in such statement of work that meet the specifications and requirements provided by Rigetti Sub. “Covered Components” may include control systems, dilution refrigerators, flexible cables, and select other non-QPU components suitable for Rigetti Sub’s quantum computing products. No statements of work were entered into by the parties in connection with the entry into the Collaboration Agreement. In addition, the parties have each agreed to invest at least $250 million over the next five years in the field of quantum computing (and Quanta’s investment will be towards personnel and capital expenditures for developing products and services and manufacturing capability in furtherance of the Rigetti Sub product roadmap). In connection with the Collaboration Agreement, on February 27, 2025, we entered into a Securities Purchase Agreement with Quanta, pursuant to which we agreed to sell and issue to Quanta in a private placement transaction 3,020,412 shares of our Common Stock at a price per share of approximately $11.59, for an aggregate value of approximately $35.0 million. The closing of the private placement transaction is transaction, which was subject to regulatory clearance. clearance, closed on April 29, 2025.
Paragraph 28 · 47% changed
Revenue decreased by $1.2 $3.7 million for the year ended December 31, 2024, 2025, when compared to the year ended December 31, 2023. 2024. The decrease was primarily mainly due to a $2.0 $1.4 million reduction in QCaaS revenue for from collaborative research and professional services contracts, and a $2.4 million reduction in revenue from sales of collaborative research materials and quantum computers. During the year ended December 31, 2025, there were no Novera ™ sales. During the year ended December 31, 2024, offset in part by higher revenue from development contracts Novera sales totaled $1.6 million. Our revenue has been negatively impacted by expiration of the National Quantum Initiative Act in September 2023 and sales of QPUs. its pending reauthorization in the United States Congress.
Paragraph 52 · 47% changed
We believe that our existing balances of cash, cash equivalents and available-for-sale investments should be sufficient to meet our anticipated operating cash needs for at least the next three years based on our current business plan, and expectations and assumptions considering current macroeconomic conditions. Our operating plan may change because of factors currently unknown, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations or other transactions. In addition, we may seek additional capital even if we believe that we have sufficient funds for current or future operating plans. We have based these estimates on assumptions that may prove to be wrong and we could use our available capital resources sooner than we currently expect, and future capital requirements and the adequacy of available funds will depend on many factors including those described in the section titled “Risk Factors” in this Annual Report on Form 10-K. If we are unable to raise capital when needed and on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs and/or other efforts. A recession or market corrections resulting from the impact of macroeconomic conditions could materially affect our business and the value of our securities.
Paragraph 15 · 46% changed
On November 27, 2024, May 29, 2025, we closed securities purchase agreements entered into an Open Market Sale AgreementTM (the “Sales Agreement”) with two institutional investors Jefferies, LLC, with respect to an At-the-Market (“ATM”) offering program, pursuant to which we received net proceeds of $96.0 million sold, from the sale of 50,000,000 shares of time to time at our common stock. On March 14, 2024, we entered into an At-the-Market Sales Agreement (the “ATM Agreement”) with B. Riley Securities, Inc. (“B. Riley”) and Needham & Company, LLC, pursuant to which we could offer and sell sole discretion, shares of our common stock from time to time having an aggregate offering price of up $350 million. The shares offered and sold in the ATM offering were issued pursuant to $100 million. a shelf registration statement on Form S-3 and the related prospectus supplement. During the year ended December 31, 2024, 2025, we received net raised gross proceeds of $97.5 $350 million from the sale of 68,809,485 30,309,780 shares of our common stock pursuant to the ATM Sales Agreement, at a weighted average price of $11.55 per share. All of the shares were sold during our second quarter ended June 30, 2025. The net proceeds from the Sales Agreement during the year ended December 31, 2025 were $346.7 million. As of December 31, 2025, there were no remaining shares available for sale pursuant to the Sales Agreement.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors302 words changed in this paragraph; it is 37% similar to last year's version.
We believe that our existing balances of cash, cash equivalents and marketable securities should available-for-sale investments will be sufficient to meet our anticipated operating cash needs for at least the next three years twelve months based on our current business plan, and expectations and assumptions considering current macroeconomic conditions. Our operating plan may change because of factors currently unknown, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations or other transactions. In addition, For example, in the future, we may seek additional to significantly increase our capital even if we believe that we have sufficient funds for current or future operating plans. Such financings may result in dilution expenditures, including to stockholders, issuance of securities with priority as to liquidation and dividend and other rights more favorable than common stock, imposition of debt covenants and repayment obligations or other restrictions that may adversely affect upgrade our business. Any funds we raise may not be sufficient to enable us to continue to implement our long-term business strategy. Further, our ability to raise additional capital may be adversely impacted by worsening global economic conditions and disruptions to and volatility in the credit and financial markets in the United States and current and future military conflicts and wars around the world including related sanctions and tariffs and trade protection measures. There can be no assurance that deterioration in credit and financial markets and confidence in economic conditions will not occur. A severe or prolonged economic downturn could result chip fabrication facility, possibly invest in a variety of risks to our business, including weakened demand new quantum chip fabrication facility and for our products and services and our ability to raise additional capital when needed on acceptable terms, if at all. If the equity and credit markets deteriorate, it may make any necessary financing more difficult, more costly, and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could impair our ability to achieve our growth strategy, could harm our financial performance and stock price, could require us to delay or abandon our business plans, and could require us to delay, limit, or substantially reduce our quantum computing development efforts. refrigerators, which would require a significant amount of cash for capital expenditures.

Source: Item 1A, 10-K 0001104659-26-023454 vs Item 1A, 10-K 0001558370-25-002499

MD&A171 words changed in this paragraph; it is 39% similar to last year's version.
On November 27, 2024, May 29, 2025, we closed securities purchase agreements entered into an Open Market Sale AgreementTM (the “Sales Agreement”) with two institutional investors Jefferies, LLC, with respect to an At-the-Market (“ATM”) offering program, pursuant to which we received net proceeds of $96.0 million sold, from the sale of 50,000,000 shares of time to time at our common stock. On March 14, 2024, we entered into an At-the-Market Sales Agreement (the “ATM Agreement”) with B. Riley Securities, Inc. (“B. Riley”) and Needham & Company, LLC, pursuant to which we could offer and sell sole discretion, shares of our common stock from time to time having an aggregate offering price of up $350 million. The shares offered and sold in the ATM offering were issued pursuant to $100 million. a shelf registration statement on Form S-3 and the related prospectus supplement. During the year ended December 31, 2024, 2025, we received net raised gross proceeds of $97.5 $350 million from the sale of 68,809,485 30,309,780 shares of our common stock pursuant to the ATM Sales Agreement, at a weighted average price of $11.55 per share. All of the shares were sold during our second quarter ended June 30, 2025. The net proceeds from the Sales Agreement during the year ended December 31, 2025 were $346.7 million. As of December 31, 2025, there were no remaining shares available for sale pursuant to the Sales Agreement.

Source: Item 7, 10-K 0001104659-26-023454 vs Item 7, 10-K 0001558370-25-002499

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of RGTI's Risk Factors and MD&A, 10-K Mar 4, 2026 against 10-K Mar 7, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
We believe that our existing balances of cash, cash equivalents and available-for-sale investments will be sufficient to meet our anticipated operating cash needs for at least the next twelve months based on our current business plan, and expectations and assumptions considering current macroeconomic conditions. Our operating plan may change because of factors currently unknown, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations or other transactions. For example, in the future, we may seek to significantly increase our capital expenditures, including to upgrade our chip fabrication facility, possibly invest in a new quantum chip fabrication facility and for additional quantum computing refrigerators, which would require a significant amount of cash for capital expenditures.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
We face significant technical and engineering challenges in completing the development of our quantum computers, producing our quantum computers at scale, achieving our targeted performance milestones, and realizing quantum advantage or LFTQC, any of which if not accomplished would adversely impact our business, financial condition, and results of operations.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
In addition, our perceived relationship with the U.S. government could adversely affect our business prospects in certain non-U.S. geographies or with certain non-U.S. governments.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
Our ability to compete successfully depends on continuous innovation, timely execution of our strategy, and achieving cost reductions and failure to do so could render our quantum computing systems obsolete or less competitive.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
Even if we successfully develop our quantum computing solution and executing our strategy, customer preferences may change, or competitors may achieve technological breakthroughs in science, physics, or manufacturing that render our technology obsolete or inferior. While it is uncertain whether such breakthroughs will occur in the near term, they may occur eventually, and any such advancement could materially impact our business, financial condition or results of operations.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
Our operating results could be below the expectations of public market analysts and investors due to a number of potential factors, including: our ability to meet our technological milestones (in a timely fashion or at all); changes in the industries in which we and our customers operate; the relative performance of our competitors; adverse impacts of global military conflicts and wars; anticipated or actual fluctuations in our operating results; publication of research reports by securities analysts about us or our competitors or our industry; rumors and market speculation involving us or our competitors, which may include short seller reports; the public’s reaction to our press releases, public announcements and filings with the SEC; our or our competitors’ failure to meet analyst projections or guidance; additions and departures of key personnel; changes in laws or regulations affecting our business, including accounting standards, policies, guidelines, interpretations and principles; involvement in litigation involving the Company, or actions by institutional or activist stockholders; future sales or issuances of our securities; the volume of our securities available for public sale or resale; and other events or factors, including recessions, increases in inflation and interest rates, disruptions to banking systems, foreign currency fluctuations, international tariffs, social, political and economic risks, natural disasters, acts of war (including the conflict involving Russia and Ukraine), terrorism or responses to such events. These market and industry factors may materially reduce the market price of our Common Stock and our Public Warrants regardless of the operating performance of the Company. In the past, following periods of market volatility, stockholders have instituted securities class action litigation. If we are involved in securities litigation, it could have a substantial cost and divert resources and the attention of executive management from our business regardless of the outcome of such litigation.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
On May 29, 2025, we filed an automatic shelf registration statement on Form S-3ASR with the SEC, which enables us to offer for sale, from time to time, an unspecified amount of Common Stock, preferred stock, debt securities and warrants. The Form S-3ASR became automatically effective upon filing and is valid for three years.
Read it in 10-K Mar 4, 2026 at sec.gov
Show the other 67
AddedRisk Factors
Under the current rules of the SEC, we will no longer be eligible to take advantage of the scaled disclosures available to smaller reporting companies beginning with our Quarterly Report on Form 10-Q for the first quarter of 2026. We expect that the loss of the ability to take advantage of scaled disclosures will result in increased legal, accounting and financial compliance costs.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
During the year ended December 31, 2025, 4,830,235 shares were issued upon the exercise of warrants. The additional shares issued resulted in dilution to the holders of Common Stock and increased the number of shares outstanding. To the extent additional warrants are exercised, stockholders may experience additional dilution. Sales of substantial shares in the public market or the fact that warrants have been and may continue to be exercised could adversely affect the market price of our Common Stock.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedRisk Factors
We have the ability to redeem outstanding Public Warrants prior to their expiration, at a redemption price of $0.01 per warrant, provided that the last reported sales price of our Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which we provide notice of redemption and certain other conditions are met. In such event, holders may exercise their warrants prior to the scheduled redemption date, but only for cash, and the market price of our Common Stock may decline below both the $18.00 redemption threshold and the $11.50 exercise price following the issuance of the redemption notice.
Read it in 10-K Mar 4, 2026 at sec.gov
RemovedRisk Factors
If we cannot evolve and scale our business and operations effectively, we may not be able to execute our business strategies in a cost-effective manner and our business, financial condition, profitability and results of operations could be adversely affected.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
We have not produced quantum computers with high qubit counts or at volume and we face significant barriers in our attempts to produce quantum computers, including the need to invent and develop new technology. If we cannot successfully overcome those barriers, our business will be negatively impacted and could fail.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
Any future generations of hardware and software developed to demonstrate narrow quantum advantage and broad quantum advantage, each of which is an important anticipated milestone for our technology roadmap and commercialization, may not occur on our anticipated timeline or at all.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
If our computers fail to achieve quantum advantage, our business, financial condition and future prospects may be harmed. Moreover, the standards by which we measure our progress may be based on assumptions and expectations that are not accurate or that may change as quantum computing evolves.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
There may be other measures that are utilized in the future to measure our progress and the progress of others in the industry and therefore undue reliance should not be placed on our current performance measures.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
If we cannot develop quantum computers that have quantum advantage, customers may not continue to purchase our products and services. If other companies’ quantum computers reach narrow quantum advantage or broad quantum advantage prior to the time we reach such capabilities, it could lead to a loss of customers. If any of these events occur, it could have a material adverse effect on our business, financial condition or results of operations.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
We rely on access to high performance third party classical computing through public clouds, high performance computing centers and on-premises computing infrastructure to deliver performant quantum solutions to customers. We may not be able to maintain high quality relationships and connectivity with these resources which could make it harder for us to reach customers or deliver solutions in a cost-effective manner.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
Further, we also entered into the Securities Purchase Agreement with Quanta in connection with the Collaboration Agreement, pursuant to which Quanta agreed to purchase in a private placement transaction certain shares of our common stock for an aggregate value of approximately $35 million (the “Private Placement”). However, the closing of the Private Placement is subject to, among other things, the expiration of a 30-day waiting period after our submission of a classification request to the Bureau of Industry and Security of the Department of Commerce (the “BIS Clearance”). If the BIS Clearance is not obtained by December 31, 2025, the Securities Purchase Agreement may be terminated by either party; in the event of such termination, the Collaboration Agreement may also be terminated by either party. If any of the termination events were to occur, we may never close the Private Placement and/or we may never realize the anticipated benefits of the Collaboration Agreement, which may have a materially adverse impact on our business operations and our financial position or results of operations.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedRisk Factors
We are reliant on third-party suppliers for components necessary to develop and manufacture our quantum computing solutions. Any of the following factors (and others) could have an adverse impact on the availability of these components:
Read it in 10-K Mar 7, 2025 at sec.gov
RewordedRisk Factors
To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, the The Certificate of Incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for state law claims for a list of enumerated actions, subject to certain exceptions, in which case the United States federal district courts shall will be the sole and exclusive forum for the resolution of resolving any complaint action asserting a cause of action claim arising under the Securities Act.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
The warrant agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or and the United States District Court for the Southern District of New York, York constitute the sole and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. claim arising out of or relating to the warrant agreement, including claims under the Securities Act.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
Alternatively, Conversely, if a court were to find this determines that the provision of our warrant agreement is inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, certain claims, we may could incur additional costs and burdens associated with resolving such matters litigating in other multiple jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of divert management’s and the Board’s time and resources of our management and board of directors. attention.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
(x) the personal jurisdiction of the New York state and federal courts located in the State for purposes of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), provision and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such through the warrant holder’s counsel in the foreign action as agent for such warrant holder. action.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
If we do not achieve economies of scale or if the these anticipated cost savings do not materialize, we may be unable to achieve a lower cost per qubit, which would make or if macroeconomic pressures such as inflation continue to increase labor and materials costs, we may be unable to price our quantum computing solution less competitive than those produced by our competitors computers competitively, and this could have a material adverse effect on our business, financial condition or results of operations.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; loss of intellectual property or other confidential business information; and other adverse consequences, which may adversely affect our business.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
The success of Our competitiveness also depends on our business is dependent upon ability to reduce the cost per qubit decreasing over the next several years as our quantum computers advance, time, which is based on achieving anticipated assumes we will be able to achieve economies of scale related to demand for our computer systems, benefit from technological innovation innovation, and negotiations negotiate favorable terms with third-party parts suppliers.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
Cybersecurity incidents such as malicious internet-based activity, online and offline fraud, denial-of-service attacks, ransomware attacks, business email compromises, computer malware, viruses, and social engineering (including through deep fakes or other attacks using artificial intelligence which may be increasingly more difficult to identify as fake, and phishing attacks) as well as natural disasters and other similar activities threaten the confidentiality, integrity, and availability of our sensitive information and information technology systems, and those of the third parties upon which we rely.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
These risks include, but are not limited to, (i) entities may also have increased purchasing power and leverage held by such customers in negotiating contractual arrangements with us and (ii) us, as well as longer sales cycles and cycles, which brings the associated risk that substantial time and resources may be spent on a potential end-customer customer that elects not to purchase our solutions. products or services.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
We have entered into, and may enter into, strategic partnerships to develop and commercialize our current and future research and development programs with other companies to accomplish one or more of the following: for purposes such as: obtaining expertise; obtaining sales and marketing services and/or support; obtaining equipment and facilities; developing relationships with potential future customers; and generating revenue.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
In particular, changes in corporate tax rates, the realization of our net deferred tax assets, the taxation of foreign earnings, earnings and the deductibility of expenses under the Tax Cuts and Jobs Act, as amended by the Coronavirus Aid, Relief, and Economic Security Act current law or any future tax reform legislation, legislation could have a material impact on the value or realization of our net deferred tax assets, result in significant one-time charges, and increase our future tax expenses.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedRisk Factors
In the twelve-month period ended December 31, 2024, 2025, the market price of our Common Stock varied between a high of $19.35 $58.15 on December 27, 2024 October 14, 2025 and a low of $0.66 $5.95 on September 9, 2024 January 13, 2025, and the market price of our Public Warrants varied between a high of $8.60 $46.78 on December 27, 2024 October 15, 2025 and a low of $0.06 $1.95 on September 23, 2024. January 13, 2025.
Read it in 10-K Mar 4, 2026 at sec.gov
Quiet changesRisk Factors
Appeals, disputes, or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government;
Read it in 10-K Mar 4, 2026 at sec.gov
Quiet changesRisk Factors
However, there There are a variety of risks and costs associated with our international sales and operations, which may include making additional investments prior to the proven adoption of our solutions, the cost of conducting our business internationally and hiring and training international employees and the costs associated with complying with local law.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
In the second quarter of 2025, we announced the public launch of our 36-qubit Cepheus-1-36Q system, our newest flagship quantum computer that utilizes our modular chip architecture and demonstrates our path to scaling to higher qubit count and higher performing systems. Made of four 9-qubit “chiplets,” we believe that Cepheus-1-36Q is the industry’s largest multi-chip quantum computer. As of January 2026, we achieved a 99.6% median two-qubit gate fidelity (based on internal testing) with Cepheus-1-36Q, successfully halving our error rate from our previous, single-chip 84-qubit Ankaa-3 system.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
Ankaa-3 and Cepheus-1-36Q are available to our partners via the Rigetti QCS platform. Cepheus-1-36Q is intended to enable users to operate our universal CZ gates for a wide range of algorithmic research, with a median gate time of 76 nanoseconds. Our CZ gates are designed to be optimized for fast gate times while reducing coherent errors, which improves fidelity and is key for executing quantum error correction techniques. Cepheus-1-36Q features scalable chip architecture with 3D signal delivery while incorporating enhancements to key technologies, such as enhanced intermodule coupler design to enable higher performance. Leveraging our full-stack platform and in-house quantum foundry capabilities, we believe that Cepheus-1-36Q demonstrates our ability to deliver increasingly higher performance quantum computers with larger qubit counts using our proprietary chiplet-based architecture.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
We are focused on continuing to improve our system performance. We recently achieved a two-qubit gate fidelity as high as 99.9% at 28 nanosecond gate speed on a prototype platform by using a new proprietary adiabatic CZ scheme. We continue to be at 99.9% one-qubit gate fidelity. In January 2026, we announced achievement of a median two-qubit gate fidelity (based on internal testing) of 99.7% on our 9-qubit system, 99.6% on our 36-qubit system and 99.0% on our 108-qubit system (Cepheus-1-108Q). Cepheus-1-108Q is based on twelve 9-qubit chiplets and leverages our proprietary modular chip architecture.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
In 2025, we received purchase orders for two Novera systems totaling approximately $5.7 million. Both systems are upgradeable, allowing the customers to increase the system qubit count for more complex computations and research. Delivery for both systems is expected in the first half of 2026.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
In January 2026, Rigetti Computing India P L, a wholly owned subsidiary of Rigetti Computing, Inc., announced that it received an $8.4 million purchase order to deliver a 108-qubit quantum computer to C-DAC. The system will be installed on-premises at C - DAC’s Bengaluru center and is expected to be deployed in the second half of 2026.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
Powered by the production of our scalable multi-chip quantum processors in Fab-1 and our full-stack product development approach, we are working to develop quantum computing systems that demonstrate clear performance advantages over classical computing alternatives for multiple high-impact application areas.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
Under the Collaboration Agreement, we will retain all rights, title and ownership to all QPU Technology (as defined in the Collaboration Agreement) and related intellectual property (“IP”) rights created in the course of activities specified in a statement of work under the Collaboration Agreement. Other than the QPU Technology and IP rights described above, to the extent there is any jointly created, invented or other developed technology in the course of the performance of activities specified in a statement of work under the Collaboration Agreement, the Company and Quanta will jointly own, and each party will hold a one-half undivided interest in, all such joint project technology and all newly-created or newly-arising IP rights with respect thereto.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
The increase in selling, general and administrative expenses during the year ended December 31, 2025, when compared to the year ended December 31, 2024, was mainly due to higher costs for proxy distribution and solicitation related to our annual meeting, which was driven by the increase in the number of beneficial owners of our common stock. In addition, lower bonus expenses were offset by higher stock-based compensation expenses for existing employees and other costs.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
As of December 31, 2025, all of the earn-out liabilities had been satisfied and the remaining liability balance is zero. We do not expect these earn-out liabilities to have any impact on the consolidated financial statements in future periods.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
We have incurred a cumulative pre-tax loss for the past three years. We expect to continue to incur losses for income tax purposes for the foreseeable future and will continue to carry a full valuation allowance for our deferred tax assets. Accordingly, we did not record a provision for income taxes for either the year ended December 31, 2025 or the year ended December 31, 2024.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
On July 4, 2025, new federal tax and budget legislation, known as the “One Big Beautiful Bill Act” (“OBBA”) was signed into law. We evaluated the impact of the OBBA and determined that its provisions did not have a material impact on our consolidated financial statements.
Read it in 10-K Mar 4, 2026 at sec.gov
AddedMD&A
With respect to our longer-term future cash requirements, we will require a significant amount of cash for expenditure as we invest in ongoing research and development and business operations, including with respect to the Collaboration Agreement with Quanta, pursuant to which we are required to invest at least $250.0 million in the field of quantum computing in furtherance of our product roadmap over a five-year period that commenced on February 27, 2025.
Read it in 10-K Mar 4, 2026 at sec.gov
RemovedMD&A
In 2025, we plan to introduce the next generation of our modular system architecture, while aiming to continue to increase fidelities. By mid-year 2025, we expect to release a 36-qubit system based on four 9-qubit chips tiled together, with a targeted 2x reduction in error rates from our error rates achieved at the end of 2024. By the end of 2025, we expect to release a system with over 100 qubits with a targeted 2x reduction in error rates from our error rates achieved at the end of 2024.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
We believe that we will be able to achieve our plans for 2025 described above and elsewhere in this Annual Report on Form 10-K; however, we face various risks and uncertainties relating to our business that could cause actual results to differ materially from our expectations stated herein. This Annual Report on Form 10-K, including this Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the section entitled “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
In February 2023, we announced an updated business strategy, including revisions to our technology roadmap. In connection with this updated strategy, we implemented a workforce reduction beginning in February 2023 to focus the organization and our resources on nearer-term strategic priorities and our efforts to achieve narrow quantum advantage.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
The reduction in the workforce impacted approximately 50 employees or 28% of our then workforce. We began implementing activities with respect to the revised business plan and reduction in workforce in February 2023. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance. We incurred a $1.0 million restructuring charge in the three months ended March 31, 2023, for severance payments and temporary healthcare coverage for effected employees. In addition to the restructuring charge, we also incurred $1.0 million of expenses for contractual severance benefits related to executive officers of the Company that were terminated in the three months ended March 31, 2023.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
In February 2023, we announced an updated business strategy, including revisions to our technology roadmap. In connection with this updated strategy, we implemented a workforce reduction in order to focus the organization and its resources on nearer-term strategic priorities. The reduction in the workforce impacted approximately 50 employees or approximately 28% of our then workforce. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
The decrease for the year ended December 31, 2024, when compared to the year ended December 31, 2023, was primarily due to $2.2 million of expense recognized in the year ended December 31, 2023 for the forward agreement with Ampere Computing and a $0.8 million impairment charge recognized in the year ended December 31, 2023 for deferred offering costs. Costs related to accounting services and public company compliance decreased by $1.2 million during the year ended December 31, 2024, because many of these activities were either performed more efficiently or have been brought in-house. These decreases were partially offset by a $1.1 million increase in stock-based compensation expenses for the year ended December 31, 2024. Stock compensation expenses were favorably impacted during the year ended December 31, 2023 due to forfeitures resulting from the February 2023 restructuring. All other expenses decreased by a cumulative $0.2 million for year ended December 31, 2024, when compared to the year ended December 31, 2023.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
In February 2023, we announced an updated business strategy, including revisions to our technology roadmap. In connection with this updated strategy, we implemented a workforce reduction in order to focus the organization and our resources on nearer-term strategic priorities. The reduction in the workforce impacted approximately 50 employees or approximately 28% of our then workforce. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
We began implementing activities with respect to our revised business plan, updated technology roadmap and reduction in workforce in February 2023, resulting in a $1.0 million restructuring charge for the year ended December 31, 2023. No further restructuring charges related to this action are expected.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
We received net proceeds of $12.8 million in 2024 and $20.5 million in 2023 from the sale of the maximum 23,648,889 shares of our common stock (inclusive of 171,008 shares issued to B. Riley in 2022 as consideration for the Purchase Agreement) pursuant to the Purchase Agreement. There are no remaining shares available for sale under the Purchase Agreement, and the Purchase Agreement has terminated.
Read it in 10-K Mar 7, 2025 at sec.gov
RemovedMD&A
The favorable impact from the various stock offerings was offset in part by principal repayments and prepayment and final payment fees of $23.3 million under the loan agreement we had with Trinity Capital Inc., net payments of $6.3 million for tax withholdings from sell-to-cover for equity award transactions and payments of $1.8 million for offering costs. In connection with the repayments, prepayment and final payment fees under the loan agreement, we terminated the loan agreement.
Read it in 10-K Mar 7, 2025 at sec.gov
RewordedMD&A
Revenue related to the sale of QPUs QPUs, quantum computing systems, including Novera™ and Cepheus™, and custom quantum computing components is recognized at a point in time, time when obligations under the terms of the contract are satisfied and control is transferred to the customer, generally upon shipment for sales of QPUs and quantum computing systems, and upon customer acceptance for sales of custom quantum computing components.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
Slight changes The increase in interest income during the years year ended December 31, 2024 and December 31, 2023 were 2025 was due to fluctuations an increase in the balances of our invested cash and available-for-sale investments resulting from our equity offerings during late 2024 and rates of interest earned on our investments. the year ended December 31, 2025.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
Riley, proceeds of $97.5 million, net of commissions, from the sale of 68.8 million shares of common stock under our ATM Agreement, Riley Securities, Inc. and Needham & Company, LLC on March 15, 2024, proceeds of $96.0 million, net of commissions, from the sale of 50.0 million shares of common stock Common Stock through a registered direct offering and proceeds of $0.6 million from the exercise of stock options and warrants.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
For further discussion of the potential impacts of macroeconomic events on our business, financial condition, and operating results, see the section titled “Risk Factors,” including the risk factor titled “Unfavorable “Unstable or unfavorable market and economic conditions in our industry and or the global economy could limit have had and may continue to have serious adverse consequences on our ability to grow our business business, financial condition and negatively affect our results of operations.” share price.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
Net cash provided by used in investing activities during the year ended December 31, 2024 decreased 2025 increased by $79.1 $324.9 million when compared to the year ended December 31, 2023, 2024, primarily due to investment of proceeds from our $350 million ATM program, resulting in higher purchases of available-for-sale securities and property and equipment, offset in part by higher maturities of available-for-sale securities.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
The increase change in loss fair value for the year ended December 31, 2025 was primarily due to fluctuations in our stock price, while the change in fair value for the year ended December 31, 2024 was primarily due to the change fluctuations in our stock price and related share price volatility.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
The increase change in loss fair value for the year ended December 31, 2025 was primarily due to fluctuations in our stock price, while the change in fair value for the year ended December 31, 2024 was primarily due to the change fluctuations in our stock price and related share price volatility.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
Negative conditions in the general economy both in the United States and abroad, including conditions resulting from changes in gross domestic product growth, inflation, interest rates, financial and credit market fluctuations, supply chain constraints, international trade relations policies including tariffs and tariffs, export controls, national security interests, pandemics, political turmoil, government shutdowns, natural catastrophes, warfare, and terrorist attacks in the United States or elsewhere, could negatively affect our business, including progress toward the development of quantum computing. computing by increasing the cost of materials and components and our operating costs.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
As of December 31, 2024 and December 31, 2023 2024, the fair value of the derivative liability for the Private Warrants earn-out liabilities was $22.8 million and $1.6 $45.9 million, respectively, with the change in the fair value of the derivative warrant earn-out liabilities recorded in the consolidated statements of operations each reporting period. operations.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
All other research Salaries and development employee related costs decreased increased by a cumulative $0.1 $4.4 million for and stock-based compensation costs increased by $3.7 million during the year ended December 31, 2024, 2025, when compared to the year ended December 31, 2023. 2024.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
Cash provided by financing activities during the year ended December 31, 2024 2025 totaled $175.5 million, reflecting proceeds of $12.8 million, net of commissions, from the sale of 10.1 million shares of common stock to B. $439.1 million.
Read it in 10-K Mar 4, 2026 at sec.gov
RewordedMD&A
Our development contracts are typically typically, time and materials, cost-share based or fixed price milestone or cost share-based contracts and the timing and amounts of revenue recognized in any given period will vary significantly based on the delivery work performed and/or satisfaction of the associated milestones and/or the work performed. performance obligations.
Read it in 10-K Mar 4, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RGTI/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.